Evaluating the Impact of Analgesic Guidelines on Opioid Prescribing for Facial Local Flap Reconstruction
Open Access
- 28 October 2026
- journal article
- research article
- Published by SAGE Publications in Ear, Nose & Throat Journal
Abstract
Objective: To evaluate the trends in opioid and nonopioid prescribing for facial local flap reconstruction in relation to the publication of guidelines by the American Academy of Otolaryngology–Head and Neck Surgery in April 2021. Methods: De-identified patient data were extracted from the TriNetX database, including individuals who received either opioid or non-opioid analgesics within 1–5 days following facial local flap reconstruction between January 1, 2013, and December 31, 2024. Prescribing trends were analyzed using interrupted time series analysis in Statistical Analysis System (SAS) version 9.4, with statistical significance defined as p < 0.05 to compare patterns in relation to the implementation of new opioid prescribing guidelines. Results: There was an initial significant decrease in the percentage of patients prescribed opioid medication by 4.23% following the publication of the guidelines (SE = 1.85; t = -2.29; p = 0.03). Following the initial period after the guideline publication, the trend continued to decrease by 0.12% per 3-month period (SE = 0.05; t = -2.33; p = 0.02). For non-opioid medication, there were no significant immediate or long-term changes after the guideline publication. Conclusions: There was an associated decrease in opioid prescribing after facial local flap reconstruction, and this was sustained after the guideline publication. No significant changes were identified for non-opioid prescribing.Keywords
This publication has 24 references indexed in Scilit:
- Chronic Rhinosinusitis and Autoimmune Diseases: A Comprehensive Large Population‐Based AnalysisLaryngoscope Investigative Otolaryngology, 2025
- Effect of otolaryngology analgesia guidelines on opioid prescribing in pediatric tonsillectomyInternational Journal of Pediatric Otorhinolaryngology, 2025
- Pediatric Adenotonsillectomy Opioid Prescriptions Before and After Practice Guidelines and American Academy of Pediatrics ChallengeOtolaryngology–Head and Neck Surgery, 2024
- Analysis of Neuropsychiatric Diagnoses After Montelukast InitiationJAMA Network Open, 2022
- Reducing opioid use in post-operative otolaryngology patients: A quality improvement projectAmerican Journal of Otolaryngology, 2021
- 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health recordsThe Lancet Psychiatry, 2021
- Effect of Perioperative Gabapentin Use on Postsurgical Pain in Patients Undergoing Head and Neck Mucosal SurgeryJAMA Otolaryngology–Head & Neck Surgery, 2018
- Association of Celecoxib Use With Decreased Opioid Requirements After Head and Neck Cancer Surgery With Free Tissue ReconstructionJAMA Otolaryngology–Head & Neck Surgery, 2018
- Opioid prescribing patterns among otolaryngologists: Crucial insights among the medicare populationThe Laryngoscope, 2018
- Trends in Opioid Analgesic–Prescribing Rates by Specialty, U.S., 2007–2012American Journal of Preventive Medicine, 2015